Prospects for Solvency II adjustments and changes to eligibility criteria for the STS label

• Risk/reward decisions: how do insurers evaluate relative value and credit risk of SRT vs other asset classes?

• Assessing the scope for expansion of the unfunded market - and the implications for buy-side dynamics

• Issuer perspectives: how do banks effectively measure counterparty risk? And how do they view role of unfunded trades as a diversification opportunity?